The role of hematopoietic growth factors in support of ifosfamide/carboplatin/etoposide chemotherapy.

Abstract

The ifosfamide/carboplatin/etoposide (ICE) combination represents an active chemotherapy regimen across a wide variety of disease types. The most common limiting toxicity for all three of these agents individually and in combination is myelosuppression. Thus, this regimen represents an ideal model to evaluate the role of hematopoietic growth factor support… (More)

Topics

Cite this paper

@article{Crawford1995TheRO, title={The role of hematopoietic growth factors in support of ifosfamide/carboplatin/etoposide chemotherapy.}, author={Julie T Crawford and Mouzopoulos George}, journal={Seminars in oncology}, year={1995}, volume={22 3 Suppl 7}, pages={18-22} }